Tolmar, INC.
At a glance
Employees500+
In business since2006
HeadquartersFort Collins, CO
US patents6
SAM.gov UEIXY42KKYJ8JZ5
CAGE code9GFX9
Incorporated inDE
LEI549300VPMMS1357VXA87
- treatments
- prostate cancer
- central precocious puberty
- long-acting injectables
- development
- healthcare providers
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Certifications
cGMP
Patents
6 US patents granted 2016–2023, 2 of them in the five years to SEP 2025, including 1 design patent.
Pharmaceuticals 4Medical technology 1
- Low-burst polymers and methods to produce polymerUS 11,717,572 · granted AUG 8, 2023
- Methods of treating testosterone deficiencyUS 11,564,933 · granted JAN 31, 2023
- Purification and decolorization of polymersUS 10,556,999 · granted FEB 11, 2020
- Corticosteroid compositionsUS 10,111,956 · granted OCT 30, 2018
- Syringe holderUS D770042 · granted OCT 25, 2016
Newest 5 shown · Granted to Tolmar, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tolmar, INC. | Fort Collins | CO | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.